网站大量收购独家精品文档,联系QQ:2885784924

Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of.doc

Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of.doc

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of

 PAGE \* MERGEFORMAT 11 Remission induction with the original program with a variety of different programs to strengthen the treatment of acute myeloid leukemia efficacy of Study: Xian Yin recorded, Li Jing, Yao Wei, Wang Jing, Lorry [Abstract] Objective: To investigate the acute myeloid leukemia (AML) remission induction of appropriate intensive treatment program. Methods: 37 patients with AML were randomly divided into groups and a variety of programs the original proposal group, in addition to recurrence, the intensive treatment were 1 to 2 years. the original regimen induced remission by the original program (DA or MA, the original remission induction chemotherapy and etoposide or teniposide or homoharringtonine base, the original program in the induction of remission by the conventional dose Ara-C to or high-dose chemotherapy and other alternative programs, a variety of programs, or high-dose group were Ara, HA, HAE, DA, DAE, MA, MAE, AA and other programs used alternately with solutions in which the original application of 2 to induce remission 3 courses. Results: The program group and a variety of programs in patients 1 year disease free survival (DFS rates were 76.5% and 70% (Pgt; 0.05,3 years DFS rates were 46.7% and 12.5% #8203;#8203;(P lt;0.05 . Conclusion: The method with repeated induction of remission intensive therapy program AML, long-term efficacy is superior to alternative treatment for a variety of different options program. [Keywords:] leukemia, myeloid, acute, drug therapy, intensive treatment, disease-free survival Patients with acute leukemia long-term survival is the key to therapeutic strategies properly formulated. Of non-hematopoietic stem cell transplantation in patients with complete remission (CR after consolidation of intensive treatment is its long-term survival of an important part, the different post-remission treatment and dose intensity the impact on patient survival has been one of the hot spots. the prevailing v

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档